{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T15:13:37Z","timestamp":1775574817042,"version":"3.50.1"},"reference-count":168,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2020,1,22]],"date-time":"2020-01-22T00:00:00Z","timestamp":1579651200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Cardiomyopathies are diseases of heart muscle, a significant percentage of which are genetic in origin. Cardiomyopathies can be classified as dilated, hypertrophic, restrictive, arrhythmogenic right ventricular or left ventricular non-compaction, although mixed morphologies are possible. A subset of neuromuscular disorders, notably Duchenne and Becker muscular dystrophies, are also characterized by cardiomyopathy aside from skeletal myopathy. The global burden of cardiomyopathies is certainly high, necessitating further research and novel therapies. Genome editing tools, which include zinc finger nucleases (ZFNs), transcription activator-like effector nucleases (TALENs) and clustered regularly interspaced short palindromic repeats (CRISPR) systems have emerged as increasingly important technologies in studying this group of cardiovascular disorders. In this review, we discuss the applications of genome editing in the understanding and treatment of cardiomyopathy. We also describe recent advances in genome editing that may help improve these applications, and some future prospects for genome editing in cardiomyopathy treatment.<\/jats:p>","DOI":"10.3390\/ijms21030733","type":"journal-article","created":{"date-parts":[[2020,1,22]],"date-time":"2020-01-22T11:17:57Z","timestamp":1579691877000},"page":"733","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Genome Editing for the Understanding and Treatment of Inherited Cardiomyopathies"],"prefix":"10.3390","volume":"21","author":[{"given":"Quynh","family":"Nguyen","sequence":"first","affiliation":[{"name":"Department of Medical Genetics, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB T6G2H7, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji Rowel Q.","family":"Lim","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB T6G2H7, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshifumi","family":"Yokota","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB T6G2H7, Canada"},{"name":"The Friends of Garrett Cumming Research & Muscular Dystrophy Canada, HM Toupin Neurological Science Research Chair, Edmonton, AB T6G2H7, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2020,1,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1056\/NEJMra0902923","article-title":"Inherited cardiomyopathies","volume":"364","author":"Watkins","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1161\/CIRCULATIONAHA.106.174287","article-title":"Contemporary definitions and classification of the cardiomyopathies: An American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functio","volume":"113","author":"Maron","year":"2006","journal-title":"Circulation"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1093\/eurheartj\/ehm342","article-title":"Classification of the cardiomyopathies: A position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases","volume":"29","author":"Elliott","year":"2008","journal-title":"Eur. Heart J."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1056\/NEJM200012073432304","article-title":"Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy","volume":"343","author":"Kamisago","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1161\/CIRCIMAGING.110.960740","article-title":"Cardiac involvement in patients with muscular dystrophies: Magnetic resonance imaging phenotype and genotypic considerations","volume":"4","author":"Verhaert","year":"2011","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"ref_6","first-page":"1202","article-title":"Antisense oligonucleotides for the treatment of cardiomyopathy in Duchenne muscular dystrophy","volume":"11","author":"Nguyen","year":"2019","journal-title":"Am. J. Transl. Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.bbadis.2006.05.010","article-title":"Dystrophin, its interactions with other proteins, and implications for muscular dystrophy","volume":"1772","author":"Ervasti","year":"2007","journal-title":"Biochim. Biophys. Acta-Mol. Basis Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/355696a0","article-title":"Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix","volume":"355","author":"Ervasti","year":"1992","journal-title":"Nature"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1136\/archdischild-2014-307962","article-title":"Recent advances in the management of Duchenne muscular dystrophy","volume":"100","author":"Strehle","year":"2015","journal-title":"Arch. Dis. Child."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1212\/WNL.39.8.1011","article-title":"Improved diagnosis of Becker muscular dystrophy by dystrophin testing","volume":"39","author":"Hoffman","year":"1989","journal-title":"Neurology"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1161\/01.CIR.94.12.3168","article-title":"Myocardial involvement is very frequent among patients affected with subclinical Becker\u2019s muscular dystrophy","volume":"94","author":"Melacini","year":"1996","journal-title":"Circulation"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1253\/circj.CJ-14-0893","article-title":"Inherited cardiomyopathies","volume":"78","author":"Towbin","year":"2014","journal-title":"Circ. J."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrcardio.2016.139","article-title":"Genome editing in cardiovascular diseases","volume":"14","author":"Strong","year":"2017","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1038\/nrg2842","article-title":"Genome editing with engineered zinc finger nucleases","volume":"11","author":"Urnov","year":"2010","journal-title":"Nat. Rev. Genet."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1073\/pnas.93.3.1156","article-title":"Hybrid restriction enzymes: Zinc finger fusions to Fok I cleavage domain","volume":"93","author":"Kim","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"10570","DOI":"10.1073\/pnas.95.18.10570","article-title":"FokI dimerization is required for DNA cleavage","volume":"95","author":"Bitinaite","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1126\/science.1204094","article-title":"TAL effectors: Customizable proteins for DNA targeting","volume":"333","author":"Bogdanove","year":"2011","journal-title":"Science"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1126\/science.1178817","article-title":"A simple cipher governs DNA recognition by TAL effectors","volume":"326","author":"Moscou","year":"2009","journal-title":"Science"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1126\/science.1178811","article-title":"Breaking the code of DNA binding specificity of TAL-type III effectors","volume":"326","author":"Boch","year":"2009","journal-title":"Science"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1534\/genetics.110.120717","article-title":"Targeting DNA double-strand breaks with TAL effector nucleases","volume":"186","author":"Christian","year":"2010","journal-title":"Genetics"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1126\/science.1225829","article-title":"A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity","volume":"337","author":"Jinek","year":"2012","journal-title":"Science"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1126\/science.1231143","article-title":"Multiplex genome engineering using CRISPR\/Cas systems","volume":"339","author":"Cong","year":"2013","journal-title":"Science"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1126\/science.1232033","article-title":"RNA-Guided Human Genome Engineering via Cas9","volume":"339","author":"Mali","year":"2013","journal-title":"Science"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nbt.2501","article-title":"Efficient genome editing in zebrafish using a CRISPR-Cas system","volume":"31","author":"Hwang","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/nbt.2507","article-title":"Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease","volume":"31","author":"Cho","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.cell.2015.09.038","article-title":"Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system","volume":"163","author":"Zetsche","year":"2015","journal-title":"Cell"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.hfc.2017.12.006","article-title":"Gene Editing and Gene-Based Therapeutics for Cardiomyopathies","volume":"14","author":"Ohiri","year":"2018","journal-title":"Heart Fail. Clin."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S0140-6736(16)31713-5","article-title":"Dilated cardiomyopathy","volume":"390","author":"Weintraub","year":"2017","journal-title":"Lancet (Lond. Engl.)"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0735-1097(97)00433-6","article-title":"Familial dilated cardiomyopathy: Cardiac abnormalities are common in asymptomatic relatives and may represent early disease","volume":"31","author":"Baig","year":"1998","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/j.jacc.2006.07.016","article-title":"Phospholamban R14 deletion results in late-onset, mild, hereditary dilated cardiomyopathy","volume":"48","author":"DeWitt","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1161\/01.CIR.0000066323.15244.54","article-title":"Hypertrophic cardiomyopathy: Distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy","volume":"107","author":"Richard","year":"2003","journal-title":"Circulation"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1161\/CIRCRESAHA.109.202440","article-title":"Evidence from human myectomy samples that MYBPC3 mutations cause hypertrophic cardiomyopathy through haploinsufficiency","volume":"105","author":"Marston","year":"2009","journal-title":"Circ. Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1161\/CIRCULATIONAHA.108.838672","article-title":"Cardiac myosin-binding protein C mutations and hypertrophic cardiomyopathy: Haploinsufficiency, deranged phosphorylation, and cardiomyocyte dysfunction","volume":"119","author":"Dooijes","year":"2009","journal-title":"Circulation"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1146\/annurev.med.052208.130419","article-title":"Arrhythmogenic cardiomyopathy: Etiology, diagnosis, and treatment","volume":"61","author":"Morgan","year":"2010","journal-title":"Annu. Rev. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.hfc.2009.12.003","article-title":"Arrhythmogenic right ventricular cardiomyopathy","volume":"6","author":"Ellinor","year":"2010","journal-title":"Heart Fail. Clin."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/S0735-1097(02)02307-0","article-title":"Prospective evaluation of relatives for familial arrhythmogenic right ventricular cardiomyopathy\/dysplasia reveals a need to broaden diagnostic criteria","volume":"40","author":"Hamid","year":"2002","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1172\/JCI27751","article-title":"Suppression of canonical Wnt\/beta-catenin signaling by nuclear plakoglobin recapitulates phenotype of arrhythmogenic right ventricular cardiomyopathy","volume":"116","author":"Lombardi","year":"2006","journal-title":"J. Clin. Investig."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1161\/CIRCRESAHA.109.196899","article-title":"Genetic fate mapping identifies second heart field progenitor cells as a source of adipocytes in arrhythmogenic right ventricular cardiomyopathy","volume":"104","author":"Lombardi","year":"2009","journal-title":"Circ. Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/cvr\/cvp183","article-title":"A potential link between peroxisome proliferator-activated receptor signalling and the pathogenesis of arrhythmogenic right ventricular cardiomyopathy","volume":"84","author":"Djouadi","year":"2009","journal-title":"Cardiovasc. Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.hfc.2010.06.005","article-title":"Left ventricular noncompaction: A new form of heart failure","volume":"6","author":"Towbin","year":"2010","journal-title":"Heart Fail. Clin."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.hfc.2009.11.005","article-title":"Genetics of restrictive cardiomyopathy","volume":"6","author":"Syrris","year":"2010","journal-title":"Heart Fail. Clin."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1002\/ajmg.a.34097","article-title":"Furthering the link between the sarcomere and primary cardiomyopathies: Restrictive cardiomyopathy associated with multiple mutations in genes previously associated with hypertrophic or dilated cardiomyopathy","volume":"155A","author":"Caleshu","year":"2011","journal-title":"Am. J. Med. Genet. A"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"D\u2019Amario, D., Gowran, A., Canonico, F., Castiglioni, E., Rovina, D., Santoro, R., Spinelli, P., Adorisio, R., Amodeo, A., and Perrucci, G. (2018). Dystrophin Cardiomyopathies: Clinical Management, Molecular Pathogenesis and Evolution towards Precision Medicine. J. Clin. Med., 7.","DOI":"10.3390\/jcm7090291"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1016\/j.jacc.2016.02.081","article-title":"Dystrophin-Deficient Cardiomyopathy","volume":"67","author":"Kamdar","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0167-5273(90)90082-G","article-title":"The incidence and evolution of cardiomyopathy in Duchenne muscular dystrophy","volume":"26","author":"Nigro","year":"1990","journal-title":"Int. J. Cardiol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0960-8966(99)00018-8","article-title":"Cardiac involvement in carriers of Duchenne and Becker muscular dystrophy","volume":"9","author":"Hoogerwaard","year":"1999","journal-title":"Neuromuscul. Disord."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.matbio.2017.07.004","article-title":"Marfan syndrome; A connective tissue disease at the crossroads of mechanotransduction, TGF\u03b2 signaling and cell stemness","volume":"71\u201372","author":"Ramirez","year":"2018","journal-title":"Matrix Biol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/ajmg.c.30068","article-title":"Recent progress towards a molecular understanding of Marfan syndrome","volume":"139","author":"Dietz","year":"2005","journal-title":"Am. J. Med. Genet. Part C Semin. Med. Genet."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/ejcts\/ezv073","article-title":"Cardiomyopathy in Marfan syndrome","volume":"49","author":"Hetzer","year":"2016","journal-title":"Eur. J. Cardio-Thorac. Surg."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1093\/cvr\/cvx014","article-title":"Barth syndrome cardiomyopathy","volume":"113","author":"Dudek","year":"2017","journal-title":"Cardiovasc. Res."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1750-1172-8-23","article-title":"Barth syndrome","volume":"8","author":"Clarke","year":"2013","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s11745-016-4229-7","article-title":"Barth Syndrome: Connecting Cardiolipin to Cardiomyopathy","volume":"52","author":"Ikon","year":"2017","journal-title":"Lipids"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s00246-015-1260-z","article-title":"Clinical Characteristics and Outcomes of Cardiomyopathy in Barth Syndrome: The UK Experience","volume":"37","author":"Kang","year":"2016","journal-title":"Pediatr. Cardiol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1093\/cvr\/cvv006","article-title":"Animal and in silico models for the study of sarcomeric cardiomyopathies","volume":"105","author":"Duncker","year":"2015","journal-title":"Cardiovasc. Res."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1046\/j.1365-2613.2003.00354.x","article-title":"Duchenne\u2019s muscular dystrophy: Animal models used to investigate pathogenesis and develop therapeutic strategies","volume":"84","author":"Collins","year":"2003","journal-title":"Int. J. Exp. Pathol."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Taghli-Lamallem, O., Planti\u00e9, E., and Jagla, K. (2016). Drosophila in the Heart of Understanding Cardiac Diseases: Modeling Channelopathies and Cardiomyopathies in the Fruitfly. J. Cardiovasc. Dev. Dis., 3.","DOI":"10.3390\/jcdd3010007"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1056\/NEJMoa1714458","article-title":"Effect of Genetic Diagnosis on Patients with Previously Undiagnosed Disease","volume":"379","author":"Splinter","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1534\/genetics.117.203067","article-title":"Model Organisms Facilitate Rare Disease Diagnosis and Therapeutic Research","volume":"207","author":"Wangler","year":"2017","journal-title":"Genetics"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"R207","DOI":"10.1093\/hmg\/ddz135","article-title":"The fruit fly at the interface of diagnosis and pathogenic mechanisms of rare and common human diseases","volume":"28","author":"Bellen","year":"2019","journal-title":"Hum. Mol. Genet."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1093\/cvr\/cvy208","article-title":"Modelling inherited cardiac disease using human induced pluripotent stem cell-derived cardiomyocytes: Progress, pitfalls, and potential","volume":"114","author":"Balk","year":"2018","journal-title":"Cardiovasc. Res."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1161\/CIRCRESAHA.117.305365","article-title":"Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes: Insights Into Molecular, Cellular, and Functional Phenotypes","volume":"117","author":"Karakikes","year":"2015","journal-title":"Circ. Res."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3233\/JND-150133","article-title":"Can Human Pluripotent Stem Cell-Derived Cardiomyocytes Advance Understanding of Muscular Dystrophies?","volume":"3","author":"Kalra","year":"2016","journal-title":"J. Neuromuscul. Dis."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1161\/CIRCRESAHA.116.309948","article-title":"A Comprehensive TALEN-Based Knockout Library for Generating Human-Induced Pluripotent Stem Cell-Based Models for Cardiovascular Diseases","volume":"120","author":"Karakikes","year":"2017","journal-title":"Circ. Res."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/nm.3545","article-title":"Modeling the mitochondrial cardiomyopathy of Barth syndrome with induced pluripotent stem cell and heart-on-chip technologies","volume":"20","author":"Wang","year":"2014","journal-title":"Nat. Med."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.1093\/eurheartj\/ehy249","article-title":"CRISPR\/Cas9 editing in human pluripotent stem cell-cardiomyocytes highlights arrhythmias, hypocontractility, and energy depletion as potential therapeutic targets for hypertrophic cardiomyopathy","volume":"39","author":"Mosqueira","year":"2018","journal-title":"Eur. Heart J."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Song, H.-Y., Chien, C.-S., Yarmishyn, A.A., Chou, S.-J., Yang, Y.-P., Wang, M.-L., Wang, C.-Y., Leu, H.-B., Yu, W.-C., and Chang, Y.-L. (2019). Generation of GLA-Knockout Human Embryonic Stem Cell Lines to Model Autophagic Dysfunction and Exosome Secretion in Fabry Disease-Associated Hypertrophic Cardiomyopathy. Cells, 8.","DOI":"10.3390\/cells8040327"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1073\/pnas.1523918113","article-title":"A mouse model for adult cardiac-specific gene deletion with CRISPR\/Cas9","volume":"113","author":"Carroll","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"24413","DOI":"10.1038\/srep24413","article-title":"Generation of heterozygous fibrillin-1 mutant cloned pigs from genome-edited foetal fibroblasts","volume":"6","author":"Umeyama","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1161\/CIRCRESAHA.116.310370","article-title":"Postnatal Cardiac Gene Editing Using CRISPR\/Cas9 With AAV9-Mediated Delivery of Short Guide RNAs Results in Mosaic Gene Disruption","volume":"121","author":"Johansen","year":"2017","journal-title":"Circ. Res."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"4786","DOI":"10.1038\/s41598-018-22936-z","article-title":"Successful knock-in of Hypertrophic Cardiomyopathy-mutation R723G into the MYH7 gene mimics HCM pathology in pigs","volume":"8","author":"Montag","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1002\/iub.2004","article-title":"Transplacental delivery of genome editing components causes mutations in embryonic cardiomyocytes of mid-gestational murine fetuses","volume":"71","author":"Nakamura","year":"2019","journal-title":"IUBMB Life"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"e09406","DOI":"10.7554\/eLife.09406","article-title":"An internal promoter underlies the difference in disease severity between N- and C-terminal truncation mutations of Titin in zebrafish","volume":"4","author":"Zou","year":"2015","journal-title":"eLife"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1126\/science.aaa5458","article-title":"HEART DISEASE. Titin mutations in iPS cells define sarcomere insufficiency as a cause of dilated cardiomyopathy","volume":"349","author":"Hinson","year":"2015","journal-title":"Science"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"pii: 128799","DOI":"10.1172\/jci.insight.128799","article-title":"Investigation of a dilated cardiomyopathy-associated variant in BAG3 using genome-edited iPSC-derived cardiomyocytes","volume":"4","author":"Lv","year":"2019","journal-title":"JCI Insight"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1161\/CIRCULATIONAHA.118.037227","article-title":"Inducible Pluripotent Stem Cell-Derived Cardiomyocytes Reveal Aberrant Extracellular Regulated Kinase 5 and Mitogen-Activated Protein Kinase Kinase 1\/2 Signaling Concomitantly Promote Hypertrophic Cardiomyopathy in RAF1-Associated Noonan Syndrome","volume":"140","author":"Miller","year":"2019","journal-title":"Circulation"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1161\/CIRCULATIONAHA.118.034624","article-title":"A Premature Termination Codon Mutation in MYBPC3 Causes Hypertrophic Cardiomyopathy via Chronic Activation of Nonsense-Mediated Decay","volume":"139","author":"Seeger","year":"2019","journal-title":"Circulation"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1161\/CIRCULATIONAHA.117.032273","article-title":"Determining the Pathogenicity of a Genomic Variant of Uncertain Significance Using CRISPR\/Cas9 and Human-Induced Pluripotent Stem Cells","volume":"138","author":"Ma","year":"2018","journal-title":"Circulation"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1038\/ncb3411","article-title":"iPSC-derived cardiomyocytes reveal abnormal TGF-\u03b2 signalling in left ventricular non-compaction cardiomyopathy","volume":"18","author":"Kodo","year":"2016","journal-title":"Nat. Cell Biol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1093\/cvr\/cvw234","article-title":"Multilevel analyses of SCN5A mutations in arrhythmogenic right ventricular dysplasia\/cardiomyopathy suggest non-canonical mechanisms for disease pathogenesis","volume":"113","author":"James","year":"2017","journal-title":"Cardiovasc. Res."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1161\/CIRCRESAHA.116.310283","article-title":"Analysis of Cardiac Myocyte Maturation Using CASAAV, a Platform for Rapid Dissection of Cardiac Myocyte Gene Function In Vivo","volume":"120","author":"Guo","year":"2017","journal-title":"Circ. Res."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1161\/HYPERTENSIONAHA.115.05183","article-title":"Exacerbating Pressure Overload-Induced Cardiac Hypertrophy: Novel Role of Adaptor Molecule Src Homology 2-B3","volume":"66","author":"Zhu","year":"2015","journal-title":"Hypertension (Dallas Tex. 1979)"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"6955","DOI":"10.1038\/ncomms7955","article-title":"Correction of human phospholamban R14del mutation associated with cardiomyopathy using targeted nucleases and combination therapy","volume":"6","author":"Karakikes","year":"2015","journal-title":"Nat. Commun."},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Kaneko, M., Hashikami, K., Yamamoto, S., Matsumoto, H., and Nishimoto, T. (2016). Phospholamban Ablation Using CRISPR\/Cas9 System Improves Mortality in a Murine Heart Failure Model. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0168486"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"3282","DOI":"10.1093\/eurheartj\/ehw307","article-title":"Genomic correction of familial cardiomyopathy in human engineered cardiac tissues","volume":"37","author":"Stillitano","year":"2016","journal-title":"Eur. Heart J."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nature23305","article-title":"Correction of a pathogenic gene mutation in human embryos","volume":"548","author":"Ma","year":"2017","journal-title":"Nature"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"4213","DOI":"10.1073\/pnas.1613203114","article-title":"Effects of systemic multiexon skipping with peptide-conjugated morpholinos in the heart of a dog model of Duchenne muscular dystrophy","volume":"114","author":"Echigoya","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1136\/adc.2007.118141","article-title":"Update on the management of Duchenne muscular dystrophy","volume":"93","author":"Manzur","year":"2008","journal-title":"Arch. Dis. Child."},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Lim, K.R.Q., Yoon, C., and Yokota, T. (2018). Applications of CRISPR\/Cas9 for the Treatment of Duchenne Muscular Dystrophy. J. Pers. Med., 8.","DOI":"10.20944\/preprints201811.0018.v1"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"175628641983347","DOI":"10.1177\/1756286419833478","article-title":"Human induced pluripotent stem cell models for the study and treatment of Duchenne and Becker muscular dystrophies","volume":"12","author":"Piga","year":"2019","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/mus.21716","article-title":"Timeline of cardiac dystrophy in 3-18-month-old MDX mice","volume":"42","author":"Loch","year":"2010","journal-title":"Muscle Nerve"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/s12195-015-0413-8","article-title":"Nanopatterned Human iPSC-Based Model of a Dystrophin-Null Cardiomyopathic Phenotype","volume":"8","author":"Macadangdang","year":"2015","journal-title":"Cell. Mol. Bioeng."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.stem.2016.01.021","article-title":"A Single CRISPR-Cas9 Deletion Strategy that Targets the Majority of DMD Patients Restores Dystrophin Function in hiPSC-Derived Muscle Cells","volume":"18","author":"Young","year":"2016","journal-title":"Cell Stem Cell"},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Echigoya, Y., Lim, K.R.Q., Nakamura, A., and Yokota, T. (2018). Multiple Exon Skipping in the Duchenne Muscular Dystrophy Hot Spots: Prospects and Challenges. J. Pers. Med., 8.","DOI":"10.3390\/jpm8040041"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"e1602814","DOI":"10.1126\/sciadv.1602814","article-title":"CRISPR-Cpf1 correction of muscular dystrophy mutations in human cardiomyocytes and mice","volume":"3","author":"Zhang","year":"2017","journal-title":"Sci. Adv."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"743890921","DOI":"10.1172\/jci.insight.95918","article-title":"Functional correction of dystrophin actin binding domain mutations by genome editing","volume":"2","author":"Kyrychenko","year":"2017","journal-title":"JCI Insight"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"eaap9004","DOI":"10.1126\/sciadv.aap9004","article-title":"Correction of diverse muscular dystrophy mutations in human engineered heart muscle by single-site genome editing","volume":"4","author":"Long","year":"2018","journal-title":"Sci. Adv."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.molcel.2018.09.002","article-title":"Genetic Modulation of RNA Splicing with a CRISPR-Guided Cytidine Deaminase","volume":"72","author":"Yuan","year":"2018","journal-title":"Mol. Cell"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1126\/science.aau1549","article-title":"Gene editing restores dystrophin expression in a canine model of Duchenne muscular dystrophy","volume":"362","author":"Amoasii","year":"2018","journal-title":"Science"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"eaav4324","DOI":"10.1126\/sciadv.aav4324","article-title":"CRISPR-Cas9 corrects Duchenne muscular dystrophy exon 44 deletion mutations in mice and human cells","volume":"5","author":"Min","year":"2019","journal-title":"Sci. Adv."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/jhg.2016.28","article-title":"Deletion of exons 3\u22129 encompassing a mutational hot spot in the DMD gene presents an asymptomatic phenotype, indicating a target region for multiexon skipping therapy","volume":"61","author":"Nakamura","year":"2016","journal-title":"J. Hum. Genet."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"33","DOI":"10.4252\/wjsc.v11.i1.33","article-title":"Current methods for the maturation of induced pluripotent stem cell-derived cardiomyocytes","volume":"11","author":"Machiraju","year":"2019","journal-title":"World J. Stem Cells"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1126\/science.1254445","article-title":"Prevention of muscular dystrophy in mice by CRISPR\/Cas9-mediated editing of germline DNA","volume":"345","author":"Long","year":"2014","journal-title":"Science"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1126\/science.2662404","article-title":"The molecular basis of muscular dystrophy in the mdx mouse: A point mutation","volume":"244","author":"Sicinski","year":"1989","journal-title":"Science"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1016\/j.ymthe.2018.08.010","article-title":"CRISPR-Induced Deletion with SaCas9 Restores Dystrophin Expression in Dystrophic Models In Vitro and In Vivo","volume":"26","author":"Cherif","year":"2018","journal-title":"Mol. Ther."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1126\/science.aad5725","article-title":"Postnatal genome editing partially restores dystrophin expression in a mouse model of muscular dystrophy","volume":"351","author":"Long","year":"2016","journal-title":"Science"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1126\/science.aad5143","article-title":"In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy","volume":"351","author":"Nelson","year":"2016","journal-title":"Science"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1126\/science.aad5177","article-title":"In vivo gene editing in dystrophic mouse muscle and muscle stem cells","volume":"351","author":"Tabebordbar","year":"2016","journal-title":"Science"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"14454","DOI":"10.1038\/ncomms14454","article-title":"Muscle-specific CRISPR\/Cas9 dystrophin gene editing ameliorates pathophysiology in a mouse model for Duchenne muscular dystrophy","volume":"8","author":"Bengtsson","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1161\/CIRCRESAHA.117.310996","article-title":"In Vivo Genome Editing Restores Dystrophin Expression and Cardiac Function in Dystrophic Mice","volume":"121","author":"Xu","year":"2017","journal-title":"Circ. Res."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"eaan8081","DOI":"10.1126\/scitranslmed.aan8081","article-title":"Single-cut genome editing restores dystrophin expression in a new mouse model of muscular dystrophy","volume":"9","author":"Amoasii","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"744080517","DOI":"10.1172\/jci.insight.124297","article-title":"AAV CRISPR editing rescues cardiac and muscle function for 18 months in dystrophic mice","volume":"3","author":"Hakim","year":"2018","journal-title":"JCI Insight"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/j.ymthe.2019.05.001","article-title":"Life-Long AAV-Mediated CRISPR Genome Editing in Dystrophic Heart Improves Cardiomyopathy without Causing Serious Lesions in mdx Mice","volume":"27","author":"Xu","year":"2019","journal-title":"Mol. Ther."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/s41591-019-0344-3","article-title":"Long-term evaluation of AAV-CRISPR genome editing for Duchenne muscular dystrophy","volume":"25","author":"Nelson","year":"2019","journal-title":"Nat. Med."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0092-8674(00)80532-2","article-title":"Utrophin-Dystrophin-Deficient Mice as a Model for Duchenne Muscular Dystrophy","volume":"90","author":"Deconinck","year":"1997","journal-title":"Cell"},{"key":"ref_115","first-page":"1314","article-title":"Dystrophin-deficient large animal models: Translational research and exon skipping","volume":"7","author":"Yu","year":"2015","journal-title":"Am. J. Transl. Res."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"5635","DOI":"10.1038\/srep05635","article-title":"Generation of muscular dystrophy model rats with a CRISPR\/Cas system","volume":"4","author":"Nakamura","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"dmm032201","DOI":"10.1242\/dmm.032201","article-title":"A novel rabbit model of Duchenne muscular dystrophy generated by CRISPR\/Cas9","volume":"11","author":"Sui","year":"2018","journal-title":"Dis. Model. Mech."},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"Yu, H.-H., Zhao, H., Qing, Y.-B., Pan, W.-R., Jia, B.-Y., Zhao, H.-Y., Huang, X.-X., and Wei, H.-J. (2016). Porcine Zygote Injection with Cas9\/sgRNA Results in DMD-Modified Pig with Muscle Dystrophy. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17101668"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"288","DOI":"10.4330\/wjc.v4.i10.288","article-title":"Next generation sequencing in cardiovascular diseases","volume":"4","author":"Faita","year":"2012","journal-title":"World J. Cardiol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s40246-015-0031-5","article-title":"Clinical application of next-generation sequencing for Mendelian diseases","volume":"9","author":"Jamuar","year":"2015","journal-title":"Hum. Genom."},{"key":"ref_121","doi-asserted-by":"crossref","unstructured":"Yang, W., Li, Y., He, F., and Wu, H. (2015). Microarray profiling of long non-coding RNA (lncRNA) associated with hypertrophic cardiomyopathy. BMC Cardiovasc. Disord., 15.","DOI":"10.1186\/s12872-015-0056-7"},{"key":"ref_122","first-page":"86","article-title":"Emerging role of microRNAs in dilated cardiomyopathy: Evidence regarding etiology","volume":"215","author":"Belmonte","year":"2019","journal-title":"Transl. Res."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s11886-018-1055-y","article-title":"Non-coding RNA in Ischemic and Non-ischemic Cardiomyopathy","volume":"20","author":"Lu","year":"2018","journal-title":"Curr. Cardiol. Rep."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.molcel.2012.07.029","article-title":"Playing the End Game: DNA Double-Strand Break Repair Pathway Choice","volume":"47","author":"Chapman","year":"2012","journal-title":"Mol. Cell"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/nbt.3190","article-title":"Increasing the efficiency of precise genome editing with CRISPR-Cas9 by inhibition of nonhomologous end joining","volume":"33","author":"Maruyama","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nbt.3198","article-title":"Increasing the efficiency of homology-directed repair for CRISPR-Cas9-induced precise gene editing in mammalian cells","volume":"33","author":"Chu","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"e04766","DOI":"10.7554\/eLife.04766","article-title":"Enhanced homology-directed human genome engineering by controlled timing of CRISPR\/Cas9 delivery","volume":"3","author":"Lin","year":"2014","journal-title":"eLife"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.stemcr.2016.07.001","article-title":"A Cas9 Variant for Efficient Generation of Indel-Free Knockin or Gene-Corrected Human Pluripotent Stem Cells","volume":"7","author":"Howden","year":"2016","journal-title":"Stem Cell Rep."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s11886-018-0998-3","article-title":"Recent Progress in Genome Editing Approaches for Inherited Cardiovascular Diseases","volume":"20","author":"Kaur","year":"2018","journal-title":"Curr. Cardiol. Rep."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1038\/s41588-018-0174-0","article-title":"CRISPR\u2013Cas9 genome editing in human cells occurs via the Fanconi anemia pathway","volume":"50","author":"Richardson","year":"2018","journal-title":"Nat. Genet."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"9363","DOI":"10.1038\/s41598-017-09716-x","article-title":"Targeted Genome Replacement via Homology-directed Repair in Non-dividing Cardiomyocytes","volume":"7","author":"Ishizu","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/nature20565","article-title":"In vivo genome editing via CRISPR\/Cas9 mediated homology-independent targeted integration","volume":"540","author":"Suzuki","year":"2016","journal-title":"Nature"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.aad5227","article-title":"Rationally engineered Cas9 nucleases with improved specificity","volume":"351","author":"Slaymaker","year":"2016","journal-title":"Science"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/nature16526","article-title":"High-fidelity CRISPR\u2013Cas9 nucleases with no detectable genome-wide off-target effects","volume":"529","author":"Kleinstiver","year":"2016","journal-title":"Nature"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nature24268","article-title":"Enhanced proofreading governs CRISPR\u2013Cas9 targeting accuracy","volume":"550","author":"Chen","year":"2017","journal-title":"Nature"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nbt.4066","article-title":"A highly specific SpCas9 variant is identified by in vivo screening in yeast","volume":"36","author":"Casini","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature26155","article-title":"Evolved Cas9 variants with broad PAM compatibility and high DNA specificity","volume":"556","author":"Hu","year":"2018","journal-title":"Nature"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"20969","DOI":"10.1073\/pnas.1906843116","article-title":"Rationally engineered Staphylococcus aureus Cas9 nucleases with high genome-wide specificity","volume":"116","author":"Tan","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_139","first-page":"109","article-title":"CRISPR\/Cas9-based epigenome editing: An overview of dCas9-based tools with special emphasis on off-target activity","volume":"164\u2013165","author":"Vojta","year":"2019","journal-title":"Methods"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/nmeth.2681","article-title":"Orthogonal Cas9 proteins for RNA-guided gene regulation and editing","volume":"10","author":"Esvelt","year":"2013","journal-title":"Nat. Methods"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.cell.2016.01.039","article-title":"Structure and Engineering of Francisella novicida Cas9","volume":"164","author":"Hirano","year":"2016","journal-title":"Cell"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/s41580-019-0131-5","article-title":"The next generation of CRISPR\u2013Cas technologies and applications","volume":"20","author":"Gersbach","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.cell.2013.08.021","article-title":"Double Nicking by RNA-Guided CRISPR Cas9 for Enhanced Genome Editing Specificity","volume":"154","author":"Ran","year":"2013","journal-title":"Cell"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nmeth.2857","article-title":"Efficient genome modification by CRISPR-Cas9 nickase with minimal off-target effects","volume":"11","author":"Shen","year":"2014","journal-title":"Nat. Methods"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1093\/nar\/gky222","article-title":"(Henry) Paired D10A Cas9 nickases are sometimes more efficient than individual nucleases for gene disruption","volume":"46","author":"Gopalappa","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1038\/mt.2016.172","article-title":"A Self-restricted CRISPR System to Reduce Off-target Effects","volume":"24","author":"Chen","year":"2016","journal-title":"Mol. Ther."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1093\/nar\/gky1165","article-title":"Synthetic switch to minimize CRISPR off-target effects by self-restricting Cas9 transcription and translation","volume":"47","author":"Shen","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1093\/nar\/gku1326","article-title":"CRISPR-based self-cleaving mechanism for controllable gene delivery in human cells","volume":"43","author":"Moore","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.molcel.2016.07.004","article-title":"Methods for Optimizing CRISPR-Cas9 Genome Editing Specificity","volume":"63","author":"Tycko","year":"2016","journal-title":"Mol. Cell"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/nbt.2673","article-title":"High-throughput profiling of off-target DNA cleavage reveals RNA-programmed Cas9 nuclease specificity","volume":"31","author":"Pattanayak","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/nbt.2808","article-title":"Improving CRISPR-Cas nuclease specificity using truncated guide RNAs","volume":"32","author":"Fu","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.biochi.2019.09.003","article-title":"Guide RNA modification as a way to improve CRISPR\/Cas9-based genome-editing systems","volume":"167","author":"Filippova","year":"2019","journal-title":"Biochimie"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"4284","DOI":"10.1038\/s41467-019-12281-8","article-title":"Optimized CRISPR guide RNA design for two high-fidelity Cas9 variants by deep learning","volume":"10","author":"Wang","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nbt.3117","article-title":"GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases","volume":"33","author":"Tsai","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nmeth.3284","article-title":"Digenome-seq: Genome-wide profiling of CRISPR-Cas9 off-target effects in human cells","volume":"12","author":"Kim","year":"2015","journal-title":"Nat. Methods"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.ymthe.2019.01.015","article-title":"Protease-Activatable Adeno-Associated Virus Vector for Gene Delivery to Damaged Heart Tissue","volume":"27","author":"Guenther","year":"2019","journal-title":"Mol. Ther."},{"key":"ref_157","doi-asserted-by":"crossref","unstructured":"Hardee, C., Ar\u00e9valo-Soliz, L., Hornstein, B., and Zechiedrich, L. (2017). Advances in Non-Viral DNA Vectors for Gene Therapy. Genes (Basel), 8.","DOI":"10.3390\/genes8020065"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1021\/acs.accounts.9b00106","article-title":"Delivery Aspects of CRISPR\/Cas for in Vivo Genome Editing","volume":"52","author":"Wilbie","year":"2019","journal-title":"Acc. Chem. Res."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/s41578-019-0145-9","article-title":"Engineered materials for in vivo delivery of genome-editing machinery","volume":"4","author":"Tong","year":"2019","journal-title":"Nat. Rev. Mater."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/s41551-017-0137-2","article-title":"Nanoparticle delivery of Cas9 ribonucleoprotein and donor DNA in vivo induces homology-directed DNA repair","volume":"1","author":"Lee","year":"2017","journal-title":"Nat. Biomed. Eng."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1161\/CIRCRESAHA.117.309711","article-title":"Classification, Epidemiology, and Global Burden of Cardiomyopathies","volume":"121","author":"McKenna","year":"2017","journal-title":"Circ. Res."},{"key":"ref_162","doi-asserted-by":"crossref","unstructured":"Wienert, B., Shin, J., Zelin, E., Pestal, K., and Corn, J.E. (2018). In vitro\u2013transcribed guide RNAs trigger an innate immune response via the RIG-I pathway. PLoS Biol., 16.","DOI":"10.1101\/275669"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1080\/10717544.2018.1474964","article-title":"Delivering CRISPR: A review of the challenges and approaches","volume":"25","author":"Lino","year":"2018","journal-title":"Drug Deliv."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1101\/gr.231936.117","article-title":"CRISPR RNAs trigger innate immune responses in human cells","volume":"28","author":"Kim","year":"2018","journal-title":"Genome Res."},{"key":"ref_165","doi-asserted-by":"crossref","unstructured":"The Lancet (2017). Genome editing: Science, ethics, and public engagement. Lancet (Lond. Engl.), 390, 625.","DOI":"10.1016\/S0140-6736(17)32209-2"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1146\/annurev-med-112717-094629","article-title":"Ethics of Human Genome Editing","volume":"70","author":"Coller","year":"2019","journal-title":"Annu. Rev. Med."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"e264","DOI":"10.1038\/mtna.2015.37","article-title":"Off-target Effects in CRISPR\/Cas9-mediated Genome Engineering","volume":"4","author":"Zhang","year":"2015","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"3497","DOI":"10.1038\/s41467-018-05843-9","article-title":"Cas9 immunity creates challenges for CRISPR gene editing therapies","volume":"9","author":"Crudele","year":"2018","journal-title":"Nat. Commun."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/21\/3\/733\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T14:08:20Z","timestamp":1760364500000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/21\/3\/733"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,22]]},"references-count":168,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,2]]}},"alternative-id":["ijms21030733"],"URL":"https:\/\/doi.org\/10.3390\/ijms21030733","relation":{"has-preprint":[{"id-type":"doi","id":"10.20944\/preprints201912.0385.v1","asserted-by":"object"}]},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,22]]}}}